IFNA2 anticorps

N° du produit ABIN6963843

Il existe 5+ publications pour ce produit. L’anticorps anti-IFNA2 Monoclonal Souris est utilisé pour la détection de IFNA2 dans des échantillons de Humain. Il a été validé pour ELISA et ELISpot.

Aperçu rapide pour IFNA2 anticorps (ABIN6963843)

Antigène: IFNA2 (Interferon, alpha 2 (IFNA2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp IFNA2 est non-conjugé

Application: ELISA, ELISpot

Clone: MT1

Détail du produit anti-IFNA2 anticorps

Specificité: Native and recombinant human IFN-α subtypes 2a, 2b, 2c

Purification: Purified from in vitro cultures by protein G affinity chromatography.

Stérilité: 0.2 μm filtered

Immunogène: Recombinant human IFN-alpha 2c

Isotype: IgG1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: supplied at 1 mg/mL in PBS with 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.

Date de péremption: 18 months

Références pour anticorps anti-IFNA2 (ABIN6963843)

Hochmann, Mittermeir, Santic, Koszik, Griessner, Sonderegger, Hoffmann, Russe, Scheiblhofer, Weiss, Mandler, Schneeberger, Strunk: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." dans: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).

Ingelsson, Söderberg, Strid, Söderberg, Bergh, Loitto, Lotfi, Segelmark, Spyrou, Rosén: "Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 3, pp. E478-E487, (2018) (PubMed).

Chan, Feeney, Leong, McLeod, Porter, Williams, Kaminskas: "An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration." dans: Biomacromolecules, Vol. 18, Issue 9, pp. 2866-2875, (2018) (PubMed).

Bijak, Dziedzic, Synowiec, Sliwinski, Saluk-Bijak: "Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes." dans: Nutrients, Vol. 9, Issue 9, (2018) (PubMed).

Hansmann, Groeger, von Wulffen, Bein, Hackstein: "Human monocytes represent a competitive source of interferon-alpha in peripheral blood." dans: Clinical immunology (Orlando, Fla.), Vol. 127, Issue 2, pp. 252-64, (2008) (PubMed).

Détails sur IFNA2

Antigène: IFNA2 (Interferon, alpha 2 (IFNA2))

Autre désignation: IFNA2

ID gène: 3440

Pathways: Signalistation JAK/STAT, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C